These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8470271)

  • 1. Lipid oxidation, vascular inflammation, and coronary atherosclerosis.
    Nilsson J
    Transplant Proc; 1993 Apr; 25(2):2063-4. PubMed ID: 8470271
    [No Abstract]   [Full Text] [Related]  

  • 2. Endothelin-1 synthesis and endothelin B receptor expression in human coronary artery smooth muscle cells and monocyte-derived macrophages is up-regulated by low density lipoproteins.
    Haug C; Schmid-Kotsas A; Zorn U; Schuett S; Gross HJ; Gruenert A; Bachem MG
    J Mol Cell Cardiol; 2001 Sep; 33(9):1701-12. PubMed ID: 11549348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New discoveries on atherosclerosis. LDL oxidation plays a central role].
    Nilsson J
    Lakartidningen; 1995 Oct; 92(40):3684-6, 3691. PubMed ID: 7564616
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vascular smooth muscle cells in coronary heart disease].
    Yoshioka S; Tsukamoto T; Chihara K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():80-5. PubMed ID: 12734957
    [No Abstract]   [Full Text] [Related]  

  • 5. Carbamylated low-density lipoprotein induces proliferation and increases adhesion molecule expression of human coronary artery smooth muscle cells.
    Asci G; Basci A; Shah SV; Basnakian A; Toz H; Ozkahya M; Duman S; Ok E
    Nephrology (Carlton); 2008 Dec; 13(6):480-6. PubMed ID: 18518940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory action of silibinin on low density lipoprotein oxidation.
    Locher R; Suter PM; Weyhenmeyer R; Vetter W
    Arzneimittelforschung; 1998 Mar; 48(3):236-9. PubMed ID: 9553679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of atherosclerosis.
    Massy ZA; Keane WF
    Semin Nephrol; 1996 Jan; 16(1):12-20. PubMed ID: 8720082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation.
    Liu SX; Hou FF; Guo ZJ; Nagai R; Zhang WR; Liu ZQ; Zhou ZM; Zhou M; Xie D; Wang GB; Zhang X
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):1156-62. PubMed ID: 16497990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atherosclerosis: activation of the injured vessel wall.
    Gotlieb AI; Wong MK
    Cardiovasc Clin; 1988; 18(2):3-21. PubMed ID: 3275417
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implications in atherosclerosis.
    Cox DA; Cohen ML
    Pharmacol Rev; 1996 Mar; 48(1):3-19. PubMed ID: 8685247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis and proliferation of endothelial cells in early atherosclerotic lesions: possible role of oxidised LDL.
    Norata GD; Tonti L; Roma P; Catapano AL
    Nutr Metab Cardiovasc Dis; 2002 Oct; 12(5):297-305. PubMed ID: 12616810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized lipid-driven chemokine receptor switch, CCR2 to CX3CR1, mediates adhesion of human macrophages to coronary artery smooth muscle cells through a peroxisome proliferator-activated receptor gamma-dependent pathway.
    Barlic J; Zhang Y; Foley JF; Murphy PM
    Circulation; 2006 Aug; 114(8):807-19. PubMed ID: 16908772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lysosomal enzymes are released from cultured human macrophages, hydrolyze LDL in vitro, and are present extracellularly in human atherosclerotic lesions.
    Hakala JK; Oksjoki R; Laine P; Du H; Grabowski GA; Kovanen PT; Pentikäinen MO
    Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1430-6. PubMed ID: 12750117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lipoproteins, antioxidants, and coronary cardiopathy].
    Guimarães AC
    Arq Bras Cardiol; 1995 Sep; 65(3):289-95. PubMed ID: 8579520
    [No Abstract]   [Full Text] [Related]  

  • 15. [The role of immune inflammation in atherogenesis].
    Nagornev VA; Rabinovich VS
    Vopr Med Khim; 1997; 43(5):339-48. PubMed ID: 9446324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Macro- and micropathology of coronary vessels].
    Mall G; Siemens I; Zimmermann R
    Verh Dtsch Ges Inn Med; 1991; 97():85-91. PubMed ID: 1808958
    [No Abstract]   [Full Text] [Related]  

  • 17. Arteriosclerosis in transplanted hearts: too much and too soon.
    Libby P; Pober JS; Swanson SJ; Mudge GH; Schoen FJ
    Can J Cardiol; 1991 Apr; 7(3):XI-XII. PubMed ID: 2044011
    [No Abstract]   [Full Text] [Related]  

  • 18. [New information on the pathophysiology of atherosclerosis].
    Reiner Z; Tedeschi-Reiner E
    Lijec Vjesn; 2001; 123(1-2):26-31. PubMed ID: 11379194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granzyme B in atherosclerosis and transplant vascular disease: association with cell death and atherosclerotic disease severity.
    Choy JC; McDonald PC; Suarez AC; Hung VH; Wilson JE; McManus BM; Granville DJ
    Mod Pathol; 2003 May; 16(5):460-70. PubMed ID: 12748253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine-mediated fibronectin production and transendothelial migration of lymphocytes in the mechanism of cardiac allograft vascular disease: efficacy of novel therapeutic approaches.
    Rabinovitch M; Molossi S; Clausell N
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S116-23. PubMed ID: 8719473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.